Publication: Quinine loading dose in cerebral malaria
dc.contributor.author | N. J. White | en_US |
dc.contributor.author | S. Looareesuwan | en_US |
dc.contributor.author | D. A. Warrell | en_US |
dc.contributor.author | M. J. Warrell | en_US |
dc.contributor.author | P. Chanthavanich | en_US |
dc.contributor.author | D. Bunnag | en_US |
dc.contributor.author | T. Harinasuta | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2018-10-12T07:35:16Z | |
dc.date.available | 2018-10-12T07:35:16Z | |
dc.date.issued | 1983-01-01 | en_US |
dc.description.abstract | In cerebral malaria, the use of currently recommended doses of intravenous quinine may results in subtherapeutic plasma concentrations during the critical first 24 hours of treatment. A loading dose of quinine (20 mg/kg quinine dihydrochloride, equivalent to 16.7 mg/kg base, infused over 4 hours) proved a rapid and safe method of achieving plasma concentrations above the high minimum inhibitory concentrations for Plasmodium falciparum prevalent in Eastern Thailand. | en_US |
dc.identifier.citation | American Journal of Tropical Medicine and Hygiene. Vol.32, No.1 (1983), 1-5 | en_US |
dc.identifier.doi | 10.4269/ajtmh.1983.32.1 | en_US |
dc.identifier.issn | 00029637 | en_US |
dc.identifier.other | 2-s2.0-0020674725 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/30478 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0020674725&origin=inward | en_US |
dc.subject | Immunology and Microbiology | en_US |
dc.subject | Medicine | en_US |
dc.title | Quinine loading dose in cerebral malaria | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0020674725&origin=inward | en_US |